229 related articles for article (PubMed ID: 30723892)
1. Aneuploidy in childhood B cell acute lymphoblastic leukaemia - also a relevant prognostic factor in relapsed disease?
Zugmaier G
Br J Haematol; 2019 Mar; 184(6):895-896. PubMed ID: 30723892
[No Abstract] [Full Text] [Related]
2. CDKN2 deletions have no prognostic value in childhood precursor-B acute lymphoblastic leukaemia.
van Zutven LJ; van Drunen E; de Bont JM; Wattel MM; Den Boer ML; Pieters R; Hagemeijer A; Slater RM; Beverloo HB
Leukemia; 2005 Jul; 19(7):1281-4. PubMed ID: 15843818
[No Abstract] [Full Text] [Related]
3. Aneuploidy in children with relapsed B-cell precursor acute lymphoblastic leukaemia: clinical importance of detecting a hypodiploid origin of relapse.
Groeneveld-Krentz S; Schroeder MP; Reiter M; Pogodzinski MJ; Pimentel-Gutiérrez HJ; Vagkopoulou R; Hof J; Chen-Santel C; Nebral K; Bradtke J; Türkmen S; Baldus CD; Gattenlöhner S; Haas OA; von Stackelberg A; Karawajew L; Eckert C; Kirschner-Schwabe R
Br J Haematol; 2019 Apr; 185(2):266-283. PubMed ID: 30714092
[TBL] [Abstract][Full Text] [Related]
4. Lack of prognostic significance of T-cell receptor delta gene rearrangements in childhood B-precursor acute lymphoblastic leukaemia.
Levett DL; Reid MM; Norden J; Middleton PG
Br J Haematol; 1998 Jul; 102(2):629-30. PubMed ID: 9695985
[No Abstract] [Full Text] [Related]
5. Frequency and prognostic impact of ZEB2 H1038 and Q1072 mutations in childhood B-other acute lymphoblastic leukemia.
Zaliova M; Potuckova E; Lukes J; Winkowska L; Starkova J; Janotova I; Sramkova L; Stary J; Zuna J; Stanulla M; Zimmermann M; Bornhauser B; Bourquin JP; Eckert C; Cario G; Trka J
Haematologica; 2021 Mar; 106(3):886-890. PubMed ID: 32499245
[No Abstract] [Full Text] [Related]
6. Thymidylate synthase gene polymorphism and its association with relapse in childhood B-cell precursor acute lymphoblastic leukemia.
Lauten M; Asgedom G; Welte K; Schrappe M; Stanulla M
Haematologica; 2003 Mar; 88(3):353-4. PubMed ID: 12651279
[No Abstract] [Full Text] [Related]
7. Identification of TCF3 germline variants in pediatric B-cell acute lymphoblastic leukemia.
Escherich C; Chen W; Miyamoto S; Namikawa Y; Yang W; Teachey DT; Li Z; Raetz EA; Larsen E; Devidas M; Martin PL; Bowman WP; Wu G; Pui CH; Hunger SP; Loh ML; Takagi M; Yang JJ
Blood Adv; 2023 May; 7(10):2177-2180. PubMed ID: 36576946
[No Abstract] [Full Text] [Related]
8. Overview on Aneuploidy in Childhood B-Cell Acute Lymphoblastic Leukemia.
Panuciak K; Nowicka E; Mastalerczyk A; Zawitkowska J; Niedźwiecki M; Lejman M
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240110
[TBL] [Abstract][Full Text] [Related]
9. Two cases of very late relapsing ALL carrying the TEL:AML1 fusion gene.
Chow CD; Dalla-Pozza L; Gottlieb DJ; Hertzberg MS
Leukemia; 1999 Nov; 13(11):1893-4. PubMed ID: 10557067
[No Abstract] [Full Text] [Related]
10. Prolonged persistence of PCR-detectable minimal residual disease after diagnosis or first relapse predicts poor outcome in childhood B-precursor acute lymphoblastic leukemia.
Steenbergen EJ; Verhagen OJ; van Leeuwen EF; van den Berg H; Behrendt H; Slater RM; von dem Borne AE; van der Schoot CE
Leukemia; 1995 Oct; 9(10):1726-34. PubMed ID: 7564517
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of T-cell receptor delta gene rearrangements in childhood B-precursor cell acute lymphoblastic leukaemia.
Díaz MA; Garcia-Sanchez F; Vicario JL; Ramirez M; Balas A; Madero L
Br J Haematol; 1997 Nov; 99(2):308-13. PubMed ID: 9375746
[TBL] [Abstract][Full Text] [Related]
12. Presence of clone-specific markers at birth in children with acute lymphoblastic leukaemia.
Hjalgrim LL; Madsen HO; Melbye M; Jørgensen P; Christiansen M; Andersen MT; Pallisgaard N; Hokland P; Clausen N; Ryder LP; Schmiegelow K; Hjalgrim H
Br J Cancer; 2002 Oct; 87(9):994-9. PubMed ID: 12434291
[TBL] [Abstract][Full Text] [Related]
13. ALLSorts: an RNA-Seq subtype classifier for B-cell acute lymphoblastic leukemia.
Schmidt B; Brown LM; Ryland GL; Lonsdale A; Kosasih HJ; Ludlow LE; Majewski IJ; Blombery P; Ekert PG; Davidson NM; Oshlack A
Blood Adv; 2022 Jul; 6(14):4093-4097. PubMed ID: 35482550
[No Abstract] [Full Text] [Related]
14. Two children with acute lymphoblastic leukemia and "jumping" translocations: both involve 1q23 as the donor breakpoint.
Jarvis A; Sharma P; Watson N; Smith A
Cancer Genet Cytogenet; 1999 Oct; 114(2):112-6. PubMed ID: 10549266
[TBL] [Abstract][Full Text] [Related]
15. DNA microarrays for comparison of gene expression profiles between diagnosis and relapse in precursor-B acute lymphoblastic leukemia: choice of technique and purification influence the identification of potential diagnostic markers.
Staal FJ; van der Burg M; Wessels LF; Barendregt BH; Baert MR; van den Burg CM; van Huffel C; Langerak AW; van der Velden VH; Reinders MJ; van Dongen JJ
Leukemia; 2003 Jul; 17(7):1324-32. PubMed ID: 12835720
[TBL] [Abstract][Full Text] [Related]
16. Clonality profile in relapsed precursor-B-ALL children by GeneScan and sequencing analyses. Consequences on minimal residual disease monitoring.
Germano G; del Giudice L; Palatron S; Giarin E; Cazzaniga G; Biondi A; Basso G
Leukemia; 2003 Aug; 17(8):1573-82. PubMed ID: 12886245
[TBL] [Abstract][Full Text] [Related]
17. [Usefulness of molecular screening in childhood lymphoblastic leukemias].
Anguita E; González FA; Contra T; Martín N; Valverde F; Villegas A
Sangre (Barc); 1998 Feb; 43(1):7-11. PubMed ID: 9577176
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide DNA methylation profiling predicts relapse in childhood B-cell acute lymphoblastic leukaemia.
Sandoval J; Heyn H; Méndez-González J; Gomez A; Moran S; Baiget M; Melo M; Badell I; Nomdedéu JF; Esteller M
Br J Haematol; 2013 Feb; 160(3):406-9. PubMed ID: 23110451
[No Abstract] [Full Text] [Related]
19. Abnormalities of the p16INK4a gene in childhood B-precursor acute lymphoblastic leukemia without nonrandom translocations: analysis of seven matched pairs of primary leukemia and corresponding cell line.
Nakamura M; Sugita K; Inukai T; Goi K; Miyamoto N; Kagami K; Okazaki-Koyama T; Mori T; Saito M; Nakazawa S
Leukemia; 2001 Jul; 15(7):1136-9. PubMed ID: 11455986
[No Abstract] [Full Text] [Related]
20. Use of clinical and laboratory features to define prognostic subgroups in B-precursor acute lymphoblastic leukemia: experience of the Pediatric Oncology Group.
Borowitz MJ; Carroll AJ; Shuster JJ; Look AT; Behm FG; Pullen DJ; Land VJ; Steuber P; Crist WM
Recent Results Cancer Res; 1993; 131():257-67. PubMed ID: 8210645
[No Abstract] [Full Text] [Related]
[Next] [New Search]